ArticleRadiation oncology (London, England)2018

A phase I dose-escalation trial of stereotactic ablative body radiotherapy for non-spine bone and lymph node metastases (DESTROY-trial).

Carole Mercier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.